Corporate venturing fund Physic Ventures has led a $15m third round of financing for T2 Biosystems, a US-based developer of portable medical diagnostic products, after the US government's Central Intelligence Agency publicly dropped out of the series C round.
Corporate venturing fund Physic Ventures has led a $15m third round of financing for T2 Biosystems, a US-based developer of portable medical diagnostic products, after the US government’s Central Intelligence Agency publicly dropped out of the series C round.
Physic Ventures is a $160m corporate venturing fund with consumer goods company Unilever as majority limited partner and including other strategic investors in drinks group Pepsi and healthcare company Humana. US venture capital firms Arcus Ventures, RA Capital, Camros Capital and…
